10-Q Filing

REGENXBIO Inc. CIK: 1590877 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0001564590-19-016531`
Period End Date	20190331
Filing Date	20190507
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	rgnx-20190331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 79 Income Statement 40 Cash Flow Statement 55 Stockholders Equity 18

Balance Sheet 79 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$71.87M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$75.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$55.85M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$244.20M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$229.37M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$8.37M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$8.59M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$6.29M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$5.73M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.83M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	36.61M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	36.12M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.00M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	36.61M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	36.12M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$337.91M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$303.88M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$150.82M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$159.08M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetNoncurrent`	$23.01M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetNoncurrent`	$22.76M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$23.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$28.70M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$6.86M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$225.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.05M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.05M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.31M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.25M	USD	Point-in-time
Total assets	`Assets`	$519.03M	USD	Point-in-time
Total assets	`Assets`	$543.81M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.41M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.20M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$17.16M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$14.19M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$600.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$600.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$22.18M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.39M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.33M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.33M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$5.48M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$1.10M	USD	Point-in-time
Financing lease obligations	`FinanceLeaseLiabilityNoncurrent`	$5.85M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.77M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$2.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$31.98M	USD	Point-in-time
Total liabilities	`Liabilities`	$34.97M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2019 and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2019 and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2019 and December 31, 2018; 36,611 and 36,120 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2019 and December 31, 2018; 36,611 and 36,120 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$602.42M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$592.58M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-720.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-59.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-83.02M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-115.32M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$487.05M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$299.34M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$183.03M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$508.85M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$543.81M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$519.03M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$132.39M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$884.00K	USD	1 Quarter
Costs of revenues	`CostOfGoodsAndServicesSold`	$29.00K	USD	1 Quarter
Costs of revenues	`CostOfGoodsAndServicesSold`	$2.41M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$25.20M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$19.55M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.38M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$11.56M	USD	1 Quarter
Other operating expenses	`OtherOperatingIncomeExpenseNet`	$-28.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$36.79M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$30.37M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$102.03M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-35.91M	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$613.00K	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$1.35M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$3.00M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$859.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$3.61M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$2.21M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$104.24M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-32.30M	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-70.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$104.24M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-32.23M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net of reclassifications and income tax expense	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-188.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net of reclassifications and income tax expense	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$621.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$621.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-188.00K	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$104.05M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-31.61M	USD	1 Quarter
Net income (loss) applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$104.24M	USD	1 Quarter
Net income (loss) applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.23M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$3.30	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.89	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$3.04	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.89	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	36.37M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	31.63M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	36.37M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	34.27M	shares	1 Quarter

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-32.23M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$104.24M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$3.29M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$5.72M	USD	1 Quarter
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-378.00K	USD	1 Quarter
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$368.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$834.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.61M	USD	1 Quarter
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$1.35M	USD	1 Quarter
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$613.00K	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-10.00K	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-327.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$51.41M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-591.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$790.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-667.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$446.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$295.00K	USD	1 Quarter
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-573.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$21.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-26.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$477.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$316.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$490.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-2.93M	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-592.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$27.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$957.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-644.00K	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-29.30M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$58.13M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$54.27M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$79.25M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$87.17M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$19.52M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.34M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.46M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-37.09M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$5.46M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$3.76M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$3.82M	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$342.00K	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$365.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.17M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.13M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-19.71M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$25.21M	USD	1 Quarter
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$46.88M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$56.91M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$76.61M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$72.09M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$46.88M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$56.91M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$76.61M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$72.09M	USD	Point-in-time

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$487.05M	USD	Point-in-time
Balances	`StockholdersEquity`	$299.34M	USD	Point-in-time
Balances	`StockholdersEquity`	$183.03M	USD	Point-in-time
Balances	`StockholdersEquity`	$508.85M	USD	Point-in-time
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.82M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.76M	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$365.00K	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$342.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.29M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.72M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net of reclassifications and income tax expense	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$621.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net of reclassifications and income tax expense	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-188.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$104.24M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-32.23M	USD	1 Quarter
Balances	`StockholdersEquity`	$487.05M	USD	Point-in-time
Balances	`StockholdersEquity`	$299.34M	USD	Point-in-time
Balances	`StockholdersEquity`	$183.03M	USD	Point-in-time
Balances	`StockholdersEquity`	$508.85M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.